The mechanisms underlying increased stroke risk and stroke-related brain damage in postmenopausal females are poorly understood. We will test the hypothesis that loss of ovarian hormones following menopause exacerbates brain damage after stroke, due to loss of cerebrovascular endothelial protective mechanisms, rendering endothelial cells (ECs) in postmenopausal women highly susceptible to ischemic injury and endothelial dysfunction. We will use in-vivo optical imaging of vascular perfusion to assess EC function in vivo, and determine if loss of ovarian hormones after reproductive senescence (RS) in middle-aged, 16-month old female mice exacerbates EC injury and dysfunction, leading to perfusion deficit and worsening brain damage after middle cerebral artery occlusion (MCAO). Mechanistically, we will determine if post-ischemic endothelial injury and dysfunction in reproductively senescent mice are linked to reduced signaling by endothelium-derived cytochrome P450 (CYP) eicosanoids called epoxyeicosatrienoic acids (EETs). Using transgenic mice with endothelial-specific overexpression of EETs-synthetic enzyme CYP2J2 (Tie2-2J2) and EETs-metabolizing enzyme soluble epoxide hydrolase (Tie2-sEH), we will determine if EC injury, perfusion deficit and reduced endothelial cell function after stroke in RS female mice are linked to sEH upregulation and loss of EETs. We will also use mice with endothelial-specific deletion of signal transducer and activator of transcription-3 (Tie2- Cre/Flox-STAT3) to determine if sEH upregulation in RS females is linked to loss of STAT3 signaling in cerebrovascular endothelium. The proposed studies examine a mechanism of injury specifically induced in postmenopausal female vessels. Selective targeting of sEH may represent a therapeutic strategy specifically tailored to and particularly effective in postmenopausal females, an age group with the highest stroke rate and mortality.
Cardiovascular disease, including stroke, is the largest single cause of death among women worldwide. Despite recent recognition that mechanisms of stroke are different between men and women, no therapy currently exists that specifically targets stroke in women. We have identified a mechanism of injury specifically induced in female brain vessels after menopause, which may serve as a target for stroke therapy particularly effective in post-menopausal females.
|Davis, Catherine M; Liu, Xuehong; Alkayed, Nabil J (2017) Cytochrome P450 eicosanoids in cerebrovascular function and disease. Pharmacol Ther 179:31-46|
|Nelson, Jonathan W; Das, Anjali J; Barnes, Anthony P et al. (2016) Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes. PLoS One 11:e0152742|
|Jia, Jia; Davis, Catherine M; Zhang, Wenri et al. (2016) Sex- and isoform-specific mechanism of neuroprotection by transgenic expression of P450 epoxygenase in vascular endothelium. Exp Neurol 279:75-85|
|Zuloaga, Kristen L; Johnson, Lance A; Roese, Natalie E et al. (2016) High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. J Cereb Blood Flow Metab 36:1257-70|
|Mittal, Nitish; Pan, Jie; Palmateer, Julie et al. (2015) So you think you can jump? A novel long jump assessment to detect deficits in stroked mice. J Neurosci Methods 256:212-9|
|Siler, Dominic A; Martini, Ross P; Ward, Jonathan P et al. (2015) Protective role of p450 epoxyeicosanoids in subarachnoid hemorrhage. Neurocrit Care 22:306-19|
|Zuloaga, Kristen L; Zhang, Wenri; Yeiser, Lauren A et al. (2015) Neurobehavioral and imaging correlates of hippocampal atrophy in a mouse model of vascular cognitive impairment. Transl Stroke Res 6:390-8|
|Nelson, Jonathan W; Zhang, Wenri; Alkayed, Nabil J et al. (2015) Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury. J Cereb Blood Flow Metab 35:1416-20|
|Young, Jennifer M; Nelson, Jonathan W; Cheng, Jian et al. (2015) Peroxisomal biogenesis in ischemic brain. Antioxid Redox Signal 22:109-20|
|Zhu, W; Dotson, A L; Libal, N L et al. (2015) Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice. Neuroscience 288:112-9|
Showing the most recent 10 out of 42 publications